We are live on ! Find out more
ALGN icon

Align Technology

153.00 USD
+3.11
2.07%
At close Updated Nov 2, 10:20 AM EST
1 day
2.07%
5 days
0.64%
1 month
6.44%
3 months
-11.5%
6 months
-10.98%
Year to date
-1.94%
1 year
10.45%
5 years
-77.06%
10 years
79.56%
 

About: Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling a lion's share of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. Invisalign treats over 2 million cases annually, or roughly 10% of all orthodontic cases and has treated over 20 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Employees: 20,435

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 13.8%
Neutral 62.1%
Negative 24.1%
Negative
Seeking Alpha
2 days ago
Align Technology: The Competitive Threat Has Eased, But Growth Remains A Concern
Align Technology faces new catalysts, developments, and litigation progress that shift the investment landscape. Market sentiment currently appears to emphasize the risks associated with ALGN over potential opportunities. I now favor an intrinsic valuation approach based on future cash flows rather than relying solely on multiples or peer averages.
Align Technology: The Competitive Threat Has Eased, But Growth Remains A Concern
Negative
Zacks Investment Research
3 days ago
ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls
Align Technology's Q3 earnings and revenues beat estimates on higher aligner shipments, but a lowered 2026 sales outlook weighs on shares.
ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls
Neutral
MarketBeat
4 days ago
Align Technology Q3 Earnings Call Highlights
Align Technology NASDAQ: ALGN reported third-quarter 2026 revenue of $1.015 billion, up 1.9% from a year earlier, as higher clear aligner volumes and international growth helped offset continued pressure in discretionary dental spending and capital-equipment purchasing.
Align Technology Q3 Earnings Call Highlights
Neutral
Seeking Alpha
4 days ago
Align Technology, Inc. (ALGN) Q3 2026 Earnings Call Transcript
Align Technology, Inc. (ALGN) Q3 2026 Earnings Call Transcript
Align Technology, Inc. (ALGN) Q3 2026 Earnings Call Transcript
Positive
Zacks Investment Research
4 days ago
Compared to Estimates, Align Technology (ALGN) Q3 Earnings: A Look at Key Metrics
The headline numbers for Align Technology (ALGN) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, Align Technology (ALGN) Q3 Earnings: A Look at Key Metrics
Positive
Zacks Investment Research
4 days ago
Align Technology (ALGN) Beats Q3 Earnings and Revenue Estimates
Align Technology (ALGN) came out with quarterly earnings of $2.8 per share, beating the Zacks Consensus Estimate of $2.76 per share. This compares to earnings of $2.61 per share a year ago.
Align Technology (ALGN) Beats Q3 Earnings and Revenue Estimates
Neutral
Business Wire
4 days ago
Align Technology Announces Third Quarter 2026 Financial Results
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the third quarter ("Q3'26"). Commenting on Align's Q3'26 results, Align Technology President and CEO Joe Hogan said, “We delivered solid third-quarter results, with.
Align Technology Announces Third Quarter 2026 Financial Results
Neutral
Business Wire
4 days ago
Align Technology Announces CEO Succession Plan
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors (“Board”) has appointed Jennifer L. Davis as the Company's next President and Chief Executive Officer, effective December 31, 2026. Davis will succee.
Align Technology Announces CEO Succession Plan
Neutral
Zacks Investment Research
6 days ago
Is the Options Market Predicting a Spike in Align Technology Stock?
Investors need to pay close attention to ALGN stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Align Technology Stock?
Neutral
Business Wire
7 days ago
Align Technology Commits Additional $1 Million to the American Association of Orthodontists Foundation to Support the Next Generation of Orthodontic Educators and Leaders
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced a new $1 million, five-year commitment to the American Association of Orthodontists (AAO) Foundation building on the Company's most recent $1 million pledge made in 2021. The commitment.
Align Technology Commits Additional $1 Million to the American Association of Orthodontists Foundation to Support the Next Generation of Orthodontic Educators and Leaders
Price charts implemented using Lightweight Charts™